Efficacy of Gemigliptin Add-on to Dapagliflozin and Metformin in Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Study (SOLUTION)

Efficacy of Gemigliptin Add-on to Dapagliflozin and Metformin in Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Study (SOLUTION)

Background This study evaluated the efficacy and safety of add-on gemigliptin in patients with type 2 diabetes mellitus (T2DM) who had inadequate glycemic control with metformin and dapagliflozin. Methods In this randomized, placebo-controlled, parallel-group, double-blind, phase III study, 315 pati...

Full description

Bibliographic Details
Main Authors: Byung Wan Lee, KyungWan Min, Eun-Gyoung Hong, Bon Jeong Ku, Jun Goo Kang, Suk Chon, Won-Young Lee, Mi Kyoung Park, Jae Hyeon Kim, Sang Yong Kim, Keeho Song, Soon Jib Yoo
Format: Article
Language:English
Published: Korean Endocrine Society 2023-06-01
Series:Endocrinology and Metabolism
Subjects:
dipeptidyl-peptidase iv inhibitors
gemigliptin
sodium-glucose transporter 2 inhibitors
dapagliflozin
metformin
diabetes mellitus, type 2
Online Access:http://www.e-enm.org/upload/pdf/enm-2023-1688.pdf

Internet

http://www.e-enm.org/upload/pdf/enm-2023-1688.pdf

Similar Items